Real-world management of atrial fibrillation in Internal Medicine units: The FADOI 'FALP' observational study

Journal of Cardiovascular Medicine

Volumn 14, Issue 1, 2013, Pages 26-34

  Campanini, Mauro ^a   Frediani, Roberto ^b   Artom, Alberto ^c   Pinna, Giuliano ^d   Valerio, Antonella ^d   La Regina, Micaela ^e   Marengo, Stefania ^f   Lo Pinto, Giuliano ^g   Del Signore, Erica ^h   Bonizzoni, Erminio ⁱ   Mathieu, Giovanni ^j   Mazzone, Antonino ^d,k   Vescovo, Giorgio ^d,l  

^a Hospital Maggiore della Carità   (Italy)

^b Hospital of Verbania   (Italy)

^c SANTA CORONA HOSPITAL   (Italy)

^d FADOI Foundation   (Italy)

^e Hospital S Andrea   (Italy)

^f MAURIZIANO HOSPITAL   (Italy)

^g GALLIERA HOSPITAL   (Italy)

^h San Andrea Hospital   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j Hospital of Pinerolo   (Italy)

^k Hospital of Legnano   (Italy)

^l Hospital San Bortolo   (Italy)

more..

Author keywords

antiarrhythmic drug; atrial fibrillation; Internal Medicine; oral anticoagulants; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLECAINIDE; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; PROPAFENONE; PROTON PUMP INHIBITOR; SOTALOL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIRECT CURRENT; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMATOLOGIC DISEASE; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFECTION; INTERNAL MEDICINE; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PNEUMONIA; PRESCRIPTION; PROGNOSIS; RESPIRATORY FAILURE; SINUS RHYTHM; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERNAL MEDICINE; ITALY; MALE; MIDDLE AGED; PATIENT DISCHARGE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84871939900     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328348e5ce     Document Type: Article

References (51)

1. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J 2010; 31:2369-2429.
2. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society ofCardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Circulation 2006; 114:e257-e354. (Pubitemid 44252297)
3. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74:236-241. (Pubitemid 24239044)
4. Feinberg WM, Blackshear JM, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155:469-473.
5. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention the An Ticoagulation and Risk Factors in Atrial fibrillation (ATRIA) study. JAMA 2001; 285:2370-2375. (Pubitemid 32424106)
6. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 1983; 106:389-396. (Pubitemid 13028244)
7. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Monitoba Follow-Up Study. Am J Med 1995; 98:476-484.
8. Flegel KM, Shipley MJ, Rose G. Risk of stroke in nonrheumatic atrial fibrillation. Lancet 1987; 1:526-529. (Pubitemid 17020736)
9. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983-988.
10. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 1999; 131:688-695. (Pubitemid 29517955)
11. Morrow JP, Reiffel JA. Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation? Pacing Clin Electrophysiol 2009; 32:108-118.
12. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008; 133:546S-592S. (Pubitemid 351892972)
13. Gage BF, Waterman AD, Shannon W, Bochler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-2870. (Pubitemid 32537350)
14. Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation stroke risk stratification in patients taking aspirin. Circulation 2004; 110:2287-2292. (Pubitemid 39407328)
15. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries. The Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26:2422-2434. (Pubitemid 41552972)
16. Meiltz A, Zimmermann M, Urban P, Bloch A, on behalf of the Association of Cardiologists of the Canton of Geneva. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 2008; 10:674-680. (Pubitemid 351775267)
17. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI.A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract 1997; 47:285-289. (Pubitemid 27208108)
18. Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA Study. Circulation 1999; 99:3028-3035. (Pubitemid 29270433)
19. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001; 86:284-288. (Pubitemid 32800076)
20. Mazzaglia G, Filippi A, Alacqua M, et al. A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. Thromb Haemost 2010; 103:968-975.
21. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure treatment: considerations for a dual epidemic. Circulation 2009; 119:2515-2525.
22. Gussoni G, Campanini M, Silingardi M, et al., on behalf of the GEMINI Study Group. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in internal medicine. Thromb Haemost 2009; 101:893-901.
23. Biagi P, Gussoni G, Iori I, et al. Clinical profile and predictors of in-hospital outcome in patients with heart failure: the FADOI 'CONFINE' study. Int J Cardiol 2011; [Epub ahead of print]
24. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993; 341:1317-1322. (Pubitemid 23148101)
25. Nabauer M, Gerth A, Limbourg T, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009; 11:423-434.
26. Anand K, Mooss AN, Hee TT, Mohiuddin SM. Meta-analysis inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006; 152:217-222. (Pubitemid 44093401)
27. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833. (Pubitemid 35417773)
28. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834-1840. (Pubitemid 35417774)
29. Oyetaio OO, Rogers CE, Hofmann PO. Dronedarone: a new antiarrhythmic agent. Pharmacotherapy 2010; 30:15-94.
30. Dorian P. Rate control in atrial fibrillation. N Engl J Med 2010; 362:1439-1441.
31. Van Gelder IC, Groenveld HF, Crijns HJGM, et al., for the RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362:1363-1373.
32. Waldo A, Becker RC, Tapson VF, Colgan KY, for the NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005; 46:1729-1736. (Pubitemid 41531631)
33. Hart RG, Pearce LA, Aguilar MI. Meta-analysis antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146:857-867. (Pubitemid 351650486)
34. Apostolakis S, Shantsila E, Lip GY, et al. Contra: 'antiplatelet therapy is an alternative to oral anticoagulation for atrial fibrillation'. Thromb Haemost 2009; 102:914-915.
35. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155:277-281.
36. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000; 320:1380-1384. (Pubitemid 30261119)
37. Monte S, Macchia A, Pellegrini F, et al. Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J 2006; 27:2217-2223. (Pubitemid 44412837)
38. Connoly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet 2006; 367:1903-1912.
39. Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial. Lancet 2007; 370:493-503. (Pubitemid 47212371)
40. 2 score ¼ 1. Thromb Haemost 2010; 103:833-840.
41. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998; 97:1231-1233. (Pubitemid 28169173)
42. Go AS, Hylek EM, Borowski LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999; 131:927-934. (Pubitemid 30005032)
43. Goto S, Bhatt DI, Rother J, et al., on behalf of the REACH Registry Investigators. Prevalence, clinical profile and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008; 156:855-863.
44. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352:1167-1171. (Pubitemid 28458530)
45. Frykman V, Beerman B, Ryden L, Rosenqvist M. Management of atrial fibrillation discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J 2001; 22:1954-1959. (Pubitemid 33054676)
46. Bravata DM, Rosenbeck K, Kancir S, Brass LM. The use of warfarin in veterans with atrial fibrillation. BMC Cardiovasc Disord 2004; 4:18.
47. Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy. J Am Coll Cardiol 2007; 50:2156-2161. (Pubitemid 350123679)
48. Lip GY. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis. Thromb Haemost 2008; 100:11-13. (Pubitemid 351948740)
49. Lip GY, Lim HS. Atrial fibrillation and stroke prevention. Lancet Neurol 2007; 6:981-993. (Pubitemid 47566414)
50. De Caterina R, Kristensen SD, Renda G. New anticoagulants for atrial fibrillation. J Cardiovasc Med (Hagerstown) 2009; 10:446-453.
51. Hylek EM. The need for new oral anticoagulants in clinical practice. J Cardiovasc Med (Hagerstown) 2009; 10:605-609.